What is Olumiant 4 mg, comprimés pelliculés used for?

( ARTG ) Rheumatoid Arthritis,OLUMIANT is indicated for the treatment of moderate to severe active rheumatoid arthritis (RA) in adult patients who have responded inadequately, or who are intolerant, to one or more DMARDs.,OLUMIANT can be taken as monotherapy or in combination with cDMARDs, including methotrexate (MTX).,Atopic Dermatitis,OLUMIANT is indicated for the treatment of moderate to severe atopic dermatitis (AD) in adult patients who are candidates for systemic therapy.,Alopecia Areata,O

What are the side effects of Olumiant 4 mg, comprimés pelliculés?

This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get. You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems . For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme

Can Olumiant 4 mg, comprimés pelliculés be used during pregnancy?

( AHT ) For the active ingredient baricitinib You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

What ATC class does Olumiant 4 mg, comprimés pelliculés belong to?

Olumiant 4 mg, comprimés pelliculés: ATC L04AA37. ATC is the WHO Anatomical Therapeutic Chemical classification — it groups drugs by organ system and pharmacological mechanism.

OTC

Olumiant 4 mg, comprimés pelliculés

Data updated: 2026-04-11

Available in:

🇩🇪🇬🇧

Form

—

Dosage

—

Route

—

Storage

—

About This Product

Manufacturer

Eli Lilly (Suisse) SA (CH)

ATC Code

User Reviews

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.